Aims and Scope
Aims:
WebLog Journal of Oncology is an open access, multidisciplinary, double-blind, meticulously peer-reviewed online journal. The journal provides a multidisciplinary forum for translational and clinical oncology research in the areas of molecular pathology, genomics, diagnosis and therapy with a specific focus on molecular targeted agents, novel immune therapies and multidisciplinary approaches to cancer management.
This journal works to accelerate the translation of experimental results into the clinic and back again into the laboratory for further investigation. The fundamental purpose of this effort is to advance clinically relevant knowledge of cancer and improve the outcome of prevention, diagnosis, and treatment of malignant disease. The journal publishes significant clinical studies from cancer programs around the world, along with important translational laboratory findings, mini-reviews (invited and submitted), and in-depth discussions of evolving and controversial topics in the oncology arena. Regardless of the trial's final findings regarding safety or efficacy, the aim is to guarantee that top-notch clinical cancer research soon reaches the public realm.
Article types that can be accepted in WebLog Journal of Oncology include Case Blogs, Case Reports, Case Series, Clinical Images, Editorials, Letters to the Editor, Short Communications, Rapid Communications, Commentaries, Perspectives, Opinions, Mini Reviews, Systematic Reviews, Review articles, and Research Articles.
An passionate group of international oncology specialists make up the Editorial Board of the Journal. Every member of the Editorial Board actively supervises and directs the publication's development. The peer-review process is based on an expert panel of reviewers who evaluate the quality and content of articles submitted for publication with the goal of disseminating accurate and practical scientific knowledge.
Scope:
WebLog Journal of Oncology widely accepts manuscripts in the following areas, but is not limited to: